248 related articles for article (PubMed ID: 7990440)
21. Neonatal hair analysis contribution to establishing a gestational drug exposure profile and predicting a withdrawal syndrome.
Vinner E; Vignau J; Thibault D; Codaccioni X; Brassart C; Humbert L; Lhermitte M
Ther Drug Monit; 2003 Aug; 25(4):421-32. PubMed ID: 12883224
[TBL] [Abstract][Full Text] [Related]
22. Bioanalysis for cocaine, opiates, methadone, and amphetamines exposure detection during pregnancy.
Concheiro M; Lendoiro E; de Castro A; Gónzalez-Colmenero E; Concheiro-Guisan A; Peñas-Silva P; Macias-Cortiña M; Cruz-Landeira A; López-Rivadulla M
Drug Test Anal; 2017 Jun; 9(6):898-904. PubMed ID: 27595432
[TBL] [Abstract][Full Text] [Related]
23. Estimates of illicit drug use during pregnancy by maternal interview, hair analysis, and meconium analysis.
Ostrea EM; Knapp DK; Tannenbaum L; Ostrea AR; Romero A; Salari V; Ager J
J Pediatr; 2001 Mar; 138(3):344-8. PubMed ID: 11241040
[TBL] [Abstract][Full Text] [Related]
24. A rapid assay for the simultaneous determination of nicotine, cocaine and metabolites in meconium using disposable pipette extraction and gas chromatography-mass spectrometry (GC-MS).
Mozaner Bordin DC; Alves MN; Cabrices OG; de Campos EG; De Martinis BS
J Anal Toxicol; 2014; 38(1):31-8. PubMed ID: 24272386
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of cocaine use during pregnancy through toxicological analysis of hair.
Chiarotti M; Strano-Rossi S; Offidani C; Fiori A
J Anal Toxicol; 1996; 20(7):555-8. PubMed ID: 8934305
[TBL] [Abstract][Full Text] [Related]
26. Relative ability of biologic specimens and interviews to detect prenatal cocaine use.
Eyler FD; Behnke M; Wobie K; Garvan CW; Tebbett I
Neurotoxicol Teratol; 2005; 27(4):677-87. PubMed ID: 15922559
[TBL] [Abstract][Full Text] [Related]
27. Meconium testing for cocaine metabolite: prevalence, perceptions, and pitfalls.
Rosengren SS; Longobucco DB; Bernstein BA; Fishman S; Cooke E; Boctor F; Lewis SC
Am J Obstet Gynecol; 1993 May; 168(5):1449-56. PubMed ID: 8498426
[TBL] [Abstract][Full Text] [Related]
28. Monitoring cocaine use in substance-abuse-treatment patients by sweat and urine testing.
Preston KL; Huestis MA; Wong CJ; Umbricht A; Goldberger BA; Cone EJ
J Anal Toxicol; 1999 Sep; 23(5):313-22. PubMed ID: 10488917
[TBL] [Abstract][Full Text] [Related]
29. Determination of opiates and cocaine in hair using automated enzyme immunoassay screening methodologies followed by gas chromatographic-mass spectrometric (GC-MS) confirmation.
Lachenmeier K; Musshoff F; Madea B
Forensic Sci Int; 2006 Jun; 159(2-3):189-99. PubMed ID: 16203118
[TBL] [Abstract][Full Text] [Related]
30. Neonatal hair analysis for benzoylecgonine: a sensitive and semiquantitative biological marker for chronic gestational cocaine exposure.
Katikaneni L; Salle FR; Hulsey TC
Biol Neonate; 2002 Jan; 81(1):29-37. PubMed ID: 11803174
[TBL] [Abstract][Full Text] [Related]
31. Assessment of exposure to opiates and cocaine during pregnancy in a Mediterranean city: preliminary results of the "Meconium Project".
Pichini S; Puig C; Zuccaro P; Marchei E; Pellegrini M; Murillo J; Vall O; Pacifici R; García-Algar O
Forensic Sci Int; 2005 Oct; 153(1):59-65. PubMed ID: 15923097
[TBL] [Abstract][Full Text] [Related]
32. Measurement of cocaine and metabolites in urine, meconium, and diapers by gas chromatography/mass spectrometry.
Lombardero N; Casanova O; Behnke M; Eyler FD; Bertholf RL
Ann Clin Lab Sci; 1993; 23(5):385-94. PubMed ID: 8239486
[TBL] [Abstract][Full Text] [Related]
33. Drug testing in biological samples vs. maternal surveys for the detection of substance use during whole pregnancy.
González-Colmenero E; Concheiro-Guisán A; Lorenzo-Martínez M; Concheiro M; Lendoiro E; de-Castro-Ríos A; Cañizo-Vázquez D; Martínez-Reglero C; Fernández-Lorenzo JR
J Addict Dis; 2021; 39(2):175-182. PubMed ID: 33043834
[TBL] [Abstract][Full Text] [Related]
34. Analysis of meconium for cocaine in neonates.
Browne SP; Tebbett IR; Moore CM; Dusick A; Covert R; Yee GT
J Chromatogr; 1992 Mar; 575(1):158-61. PubMed ID: 1517294
[TBL] [Abstract][Full Text] [Related]
35. Cocaine metabolite (benzoylecgonine) in hair and urine of drug users.
Martinez F; Poet TS; Pillai R; Erickson J; Estrada AL; Watson RR
J Anal Toxicol; 1993; 17(3):138-42. PubMed ID: 8336486
[TBL] [Abstract][Full Text] [Related]
36. Detection of cocaine and its metabolites in human amniotic fluid.
Ripple MG; Goldberger BA; Caplan YH; Blitzer MG; Schwartz S
J Anal Toxicol; 1992; 16(5):328-31. PubMed ID: 1294840
[TBL] [Abstract][Full Text] [Related]
37. Surface-activated chemical ionization ion trap mass spectrometry for the analysis of cocaine and benzoylecgonine in hair after extraction and sample dilution.
Cristoni S; Basso E; Gerthoux P; Mocarelli P; Gonella E; Brambilla M; Crotti S; Bernardi LR
Rapid Commun Mass Spectrom; 2007; 21(15):2515-23. PubMed ID: 17610217
[TBL] [Abstract][Full Text] [Related]
38. m-Hydroxybenzoylecgonine: an important contributor to the immunoreactivity in assays for benzoylecgonine in meconium.
Steele BW; Bandstra ES; Wu NC; Hime GW; Hearn WL
J Anal Toxicol; 1993 Oct; 17(6):348-52. PubMed ID: 8271781
[TBL] [Abstract][Full Text] [Related]
39. Clinical utilization of the neonatal hair test for cocaine: a four-year experience in Toronto.
Ursitti F; Klein J; Koren G
Biol Neonate; 1997; 72(6):345-51. PubMed ID: 9428994
[TBL] [Abstract][Full Text] [Related]
40. Accumulation of cocaine in maternal and fetal hair; the dose response curve.
Forman R; Schneiderman J; Klein J; Graham K; Greenwald M; Koren G
Life Sci; 1992; 50(18):1333-41. PubMed ID: 1560733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
